CompARE: study protocol for a phase III randomised controlled platform trial comparing alternative regimens for escalating treatment of intermediate and high-risk oropharyngeal cancer

Peer Review reports

Original Submission
26 Sep 2023	Submitted	Original manuscript
4 Dec 2023	Reviewed	Reviewer Report - Kirsty Loudon
14 Dec 2023	Author responded	Author comments - Hisham Mehanna
Resubmission - Version 2
14 Dec 2023	Submitted	Manuscript version 2
Publishing
15 Dec 2023	Editorially accepted
15 Jan 2024	Article published	10.1186/s13063-023-07881-1

Back to article page